[Cancer pain in palliative medicine].
During the course of cancer progression up to 90% of the patients suffer from pain of nociceptive, neuropathic or mixed nociceptive/neuropathic origin. Psychological, social or existential factors may additionally affect the intensity of pain (concept of "total pain"). The WHO "analgesic ladder" provides a large variety of effective drugs that can be used according to the specific pain type. Parenteral or peridural opioid therapy as well as neurodestructive methods can effectively support the analgesic treatment in selected cases.
Klinik für Anästhesiologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Langenbeckstrasse 1, 55131 Mainz, Deutschland. rita.laufenberg@unimedizin-mainz.de
R
R
Laufenberg-Feldmann
R
R
Schwab
R
R
Rolke
M
M
Weber
D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002404:Catheterization; D004359:Drug Therapy, Combination; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D019635:Neurosurgical Procedures; D010147:Pain Measurement; D010148:Intractable Pain / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D010166:Palliative Care; D013727:Terminal Care
D000700:Analgesics; D000701:Analgesics, Opioid; D000927:Anticonvulsants